RSPO2 and cholangiocarcinoma: Of these, promoter CpG methylation was found to inactivate RSPO1, RSPO2 and RSPO3 in acute lymphocytic leukemia, CRC, and cholangiocarcinoma, respectively 16, 28, 29.